News
Tests in 1,225 patients with the most deadly form of skin cancer reveal for the first time a genetic trait among most of ...
21m
News Medical on MSNDANTE trial reveals promising outcomes for shortened immunotherapy in advanced melanomaReducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...
Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...
13m
News Medical on MSNGenetic mutation identified as key factor in immunotherapy resistance for melanomaTests in 1,225 patients with the most deadly form of skin cancer reveal for the first time a genetic trait among most of ...
Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.
CHENNAI: Shares of Dr Reddy’s Laboratories surged over 3% in early trade on Thursday after the Indian drug maker announced a ...
Study published in New England Journal of Medicine shows that the use of immunotherapy with chemotherapy before lung cancer surgery reduces the risk of cancer returning and improves long term survival ...
2h
New York Magazine on MSNWhat’s It Like to Have Cancer for 20 Years?In An Exercise in Uncertainty, Jon Gluck traces decades of waiting, watching, enduring experimental treatment, and ...
At the heart of innovation is T-win®, a groundbreaking vaccine platform that could change how we treat cancer.
By Nancy Lapid (Reuters) -In older women diagnosed with breast cancer, use of estrogen creams to treat menopause symptoms was ...
Interim results from the global MATTERHORN study mark the first time an immunotherapy has demonstrated statistically ...
The investment bank says funding was down 57% last month, to $2.7 billion, and argues the new administration’s FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results